17-801024-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022463.5(NXN):āc.1233G>Cā(p.Glu411Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000311 in 1,573,262 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022463.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NXN | NM_022463.5 | c.1233G>C | p.Glu411Asp | missense_variant | 8/8 | ENST00000336868.8 | NP_071908.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NXN | ENST00000336868.8 | c.1233G>C | p.Glu411Asp | missense_variant | 8/8 | 1 | NM_022463.5 | ENSP00000337443.3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152184Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000310 AC: 7AN: 225854Hom.: 0 AF XY: 0.0000407 AC XY: 5AN XY: 122768
GnomAD4 exome AF: 0.0000281 AC: 40AN: 1421078Hom.: 0 Cov.: 31 AF XY: 0.0000340 AC XY: 24AN XY: 706038
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152184Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 28, 2021 | The c.1233G>C (p.E411D) alteration is located in exon 8 (coding exon 8) of the NXN gene. This alteration results from a G to C substitution at nucleotide position 1233, causing the glutamic acid (E) at amino acid position 411 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at